Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital

J Pharmacol Exp Ther. 1992 Nov;263(2):480-5.

Abstract

The development of cross-tolerance to various alcohols and pentobarbital was examined in ethanol (EtOH)-treated mice. Chronic EtOH treatment (dosage rising in steps from 3.5-4.5 g/kg i.p. daily during a 23-day period) produced tolerance to its hypnotic effect. Such tolerance was seen as a reduction in the duration of loss of righting reflex (LRR), as well as higher blood EtOH levels at the offset of LRR, in EtOH-treated mice as compared to saline-treated controls. Cross-tolerance was shown by shifts in dose-response curves for the LRR induced by n-propanol and t-butanol. Such treatment, however, did not confer functional cross-tolerance to n-butanol and pentobarbital. Because n-butanol and pentobarbital are more lipid-soluble, whereas EtOH, n-propanol and t-butanol have low degrees of lipid solubility, the development of cross-tolerance among these sedative-hypnotic drugs might be related to their relative degrees of lipid solubility.

MeSH terms

  • 1-Butanol
  • 1-Propanol / blood
  • 1-Propanol / pharmacology
  • Analysis of Variance
  • Animals
  • Butanols / blood
  • Butanols / pharmacology
  • Drug Tolerance
  • Ethanol / administration & dosage*
  • Ethanol / blood
  • Ethanol / pharmacology
  • Hypnotics and Sedatives / administration & dosage*
  • Male
  • Mice
  • Pentobarbital / blood
  • Pentobarbital / pharmacology
  • Reflex / drug effects
  • Sleep / drug effects

Substances

  • Butanols
  • Hypnotics and Sedatives
  • Ethanol
  • 1-Butanol
  • 1-Propanol
  • Pentobarbital